Phase II Trial of Angiotensin-(1-7) for the Treatment of Patients with Metastatic Sarcoma

Table 1

Patient characteristics.

Parameter	(%) or mean ± SD; (min–max)
Age (years)	55 (22–78)
Gender
Male	11 (55)
Female	9 (45)
Race
Caucasian	19 (95)
African American	1 (5)
Ethnicity
Hispanic	2 (10)
Non-Hispanic	18 (90)
Sarcoma diagnosis
Angiosarcoma	1 (5)
Chondrosarcoma	2 (10)
Epithelioid hemangioendothelioma	1 (5)
Hemangiopericytoma	1 (5)
Leiomyosarcoma	4 (20)
Malignant phyllodes	1 (5)
Mesothelioma	1 (5)
Osteosarcoma	3 (15)
Pleomorphic sarcoma (MFH/UPS)	4 (20)
Sclerosing epithelioid fibrosarcoma	1 (5)
Synovial sarcoma	1 (5)
Prior treatment
Surgery	18 (90)
Radiation therapy	8 (40)
Chemotherapy	20 (100)